Thu, 04 Aug, 2016
Shares in Shire rose to its highest level in 10 months in London after the US Food and Drug Administration approved its Xiidra drops to treat dry-eye disease, the first treatment for the ailment to be approved in more than a decade.
Wed, 13 Jul, 2016
Pfizer, which last month abandoned its $160 billion (€140bn) quest for Allergan — a deal which was controversially driven by a so-called tax inversion based on Ireland’s low tax regime — reported quarterly results that blew past analyst estimates.
Wed, 04 May, 2016
Following months of debate, the European Parliament voted on April 15 to adopt the Trade Secrets Directive. Following the approval of the parliament, the council should formally adopt the directive at its next sitting on May 17.
Mon, 25 Apr, 2016
Wed, 27 Jan, 2016
US Democratic presidential candidate Hillary Clinton will unveil proposals to deter US companies from shifting profits overseas, including an “exit tax” to penalise firms that perform so-called tax inversions, a campaign official said.
Tue, 08 Dec, 2015
Tue, 24 Nov, 2015
Pfizer’s talks to acquire botox-maker Allergan in a $150bn (€140.8bn) deal, the global drug industry’s largest ever, that would see the US drug giant re-domicile in Ireland accelerated yesterday, even as the US Treasury prepared to clamp down further on such tax inversions.
Fri, 20 Nov, 2015
Pharmaceutical giant Shire, which is headquartered in Ireland for tax purposes, has agreed to buy US rare disease specialist Dyax Corp for about $5.9bn (€5.35bn), and potentially up to $6.5bn, while still pursuing a five- times larger unsolicited bid for biopharma firm Baxalta Inc.
Tue, 03 Nov, 2015